Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kymera Therapeutics, Inc.

46.18
-0.1700-0.37%
Post-market: 46.180.00000.00%17:31 EDT
Volume:501.45K
Turnover:23.29M
Market Cap:3.24B
PE:-14.84
High:47.30
Open:46.74
Low:46.00
Close:46.35
Loading ...
May 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 11, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 18, 2022

Major Issues Report

8-K - Current report
Dec 27, 2021

Major Issues Report

8-K - Current report
Dec 16, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2021

Major Issues Report

8-K - Current report
Sep 16, 2021

Major Issues Report

8-K - Current report
Aug 06, 2021

Major Issues Report

8-K - Current report
Aug 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 28, 2021

Correspondence

CORRESP [Cover] - Correspondence